Enveric Biosciences (ENVB) Institutional Ownership $1.31 -0.04 (-2.96%) Closing price 04:00 PM EasternExtended Trading$1.29 -0.02 (-1.45%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Enveric Biosciences (NASDAQ:ENVB)CurrentInstitutional OwnershipPercentage13.82%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.99MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$41.90K Get ENVB Insider Trade Alerts Want to know when executives and insiders are buying or selling Enveric Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ENVB Institutional Buying and Selling by Quarter Enveric Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/12/2025Virtu Financial LLC25,622$36K0.0%-54.1%1.036% 2/14/2025AdvisorShares Investments LLC599,854$215K0.0%+63.4%88.214% 8/8/2024AdvisorShares Investments LLC317,047$190K0.0%+32.7%3.988% 5/20/2024Virtu Financial LLC33,835$34K0.0%N/A0.437% 2/13/2024Armistice Capital LLC273,000$355K0.0%N/A9.964% 11/6/2023AdvisorShares Investments LLC146,833$339K0.1%+46.2%6.729% 8/9/2023AdvisorShares Investments LLC100,429$338K0.1%-29.8%4.828% 5/9/2023AdvisorShares Investments LLC143,016$240K0.1%+23.0%6.876% 8/12/2022Ikarian Capital LLC223,834$48K0.0%-47.2%21.237% 8/8/2022AdvisorShares Investments LLC1,252,390$268K0.1%+35.8%118.823% Get the Latest News and Ratings for ENVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. 5/10/2022Mirae Asset Global Investments Co. Ltd.286,267$94K0.0%-27.1%0.544% 5/9/2022AdvisorShares Investments LLC922,371$304K0.1%+206.9%1.754% 2/8/2022Mirae Asset Global Investments Co. Ltd.392,920$365K0.0%N/A1.252% 1/31/2022AdvisorShares Investments LLC300,524$279K0.0%+740.5%0.958% 11/16/2021Squarepoint Ops LLC13,273$27K0.0%N/A0.062% 11/12/2021Renaissance Technologies LLC492,553$1.02M0.0%N/A2.298% 11/12/2021Vident Investment Advisory LLC25,152$52K0.0%N/A0.117% 11/12/2021Scotia Capital Inc.94,395$195K0.0%N/A0.440% 11/9/2021BlackRock Inc.500,078$1.04M0.0%-1.8%2.334% 11/4/2021AdvisorShares Investments LLC35,754$74K0.0%N/A0.167% 9/17/2021Virtu Financial LLC52,943$126K0.0%-70.8%0.247% 8/16/2021State Street Corp88,886$212K0.0%N/A0.416% 8/13/2021Northern Trust Corp36,504$87K0.0%+228.5%0.171% 8/13/2021Geode Capital Management LLC98,894$235K0.0%+56.7%0.462% 8/12/2021Penserra Capital Management LLC26,986$52K0.0%N/A0.126% 8/4/2021Creative Planning17,577$42K0.0%N/A0.082% 5/19/2021Virtu Financial LLC181,254$556K0.0%+1,623.9%0.828% 5/17/2021Schonfeld Strategic Advisors LLC20,400$62K0.0%N/A0.093% 5/13/2021Bank of New York Mellon Corp21,021$65K0.0%N/A0.096% 5/12/2021Northern Trust Corp11,111$34K0.0%N/A0.051% 5/12/2021Geode Capital Management LLC63,094$193K0.0%N/A0.288% 5/12/2021UBS Group AG31,472$97K0.0%N/A0.144% 5/7/2021BlackRock Inc.563,520$1.73M0.0%N/A2.575% (Data available from 1/1/2016 forward) ENVB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ENVB shares? During the previous two years, the following institutional investors and hedge funds held shares of Enveric Biosciences shares: Armistice Capital LLC ($355K), and AdvisorShares Investments LLC ($215K), Virtu Financial LLC ($36K).Learn more on Enveric Biosciences' institutional investors. What percentage of Enveric Biosciences' stock is owned by institutional investors? 13.82% of Enveric Biosciences' stock is owned by institutional investors. Learn more on ENVB's institutional investor holdings. Which institutional investors have been buying Enveric Biosciences' stock? The following institutional investors have purchased Enveric Biosciences' stock in the last 24 months: AdvisorShares Investments LLC ($357.43K), Armistice Capital LLC ($273K), and Virtu Financial LLC ($33.84K). How much institutional buying is happening at Enveric Biosciences? Institutional investors have bought a total of 311,021 shares in the last 24 months. This purchase volume represents approximately $1.99M in transactions. Which of Enveric Biosciences' major shareholders have been selling company stock? The following institutional investors have sold Enveric Biosciences stock in the last 24 months: Virtu Financial LLC ($30.14K). How much institutional selling is happening at Enveric Biosciences? Institutional investors have sold a total of 30,141 shares in the last 24 months. This volume of shares sold represents approximately $41.90K in transactions. Related Companies SONN Major Shareholders NXTC Major Shareholders LPTX Major Shareholders IMCC Major Shareholders SNPX Major Shareholders BTAI Major Shareholders NERV Major Shareholders PHIO Major Shareholders BGXX Major Shareholders EQ Major Shareholders This page (NASDAQ:ENVB) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
